There are 176 resources available
48P - The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy
Presenter: Paola Tiberio
Session: Poster display session
49P - Impact of cyclin D1/T_RII cells in the sensitivity to tamoxifen in hormone-receptor positive breast cancer
Presenter: Nataliya Babyshkina
Session: Poster display session
50P - Transcriptomic Profiles of CD32b in Breast Cancer Predict Outcome and Are Associated with Immune Activation.
Presenter: Katerin Rojas Laimito
Session: Poster display session
51P - Deep dive in TNBC is a need in the era of precision medicine .
Presenter: Heba Bakri
Session: Poster display session
52P - Affordable Cancer Research for Under-Resourced Settings to Implement Precision Medicine: The Tale of the Moroccan OVANORDEST-1 Study
Presenter: Khalid EL BAIRI
Session: Poster display session
53P - The role of p53 gene suppressor and bcl-2 oncoprotein in germ cell ovarian tumor prognosis determination among child and adolescent patients.
Presenter: Anvar Shukullaev
Session: Poster display session
54P - EGFR amplification is a putative resistance mechanism for NSCLC-LM patients with TKI therapy and is associated with poor outcome
Presenter: hainan Yang
Session: Poster display session
55P - Comparison of BiomeOne and PD-L1 expression tests as a predictor for response to immune checkpoint inhibitors (ICI) in patients with non-small cell lung cancer (NSCLC)
Presenter: Irina Robinson
Session: Poster display session
56P - The prognostic role of KRAS mutations in patients with early stage lung adenocarcinoma after robotic lobectomy and systematic lymphadenectomy
Presenter: Filippo Tommaso Gallina
Session: Poster display session
57P - Prognostic relationship between EGFR over expression and enrichment of CD8+ T cell within tumour microenvironment in patients with head and neck squamous cell carcinoma
Presenter: Bujin Erdene-Ochir
Session: Poster display session